Gut microbiota, its role in induction of Alzheimer’s disease pathology, and possible therapeutic interventions: Special focus on anthocyanins

Khan, M. S., Ikram, M., Park, J. S., Park, T. J. and Kim, M. O. (2020) Gut microbiota, its role in induction of Alzheimer’s disease pathology, and possible therapeutic interventions: Special focus on anthocyanins. Cells, 9(4), e853. (doi: 10.3390/cells9040853) (PMID:32244729) (PMCID:PMC7226756)

[img]
Preview
Text
213283.pdf - Published Version
Available under License Creative Commons Attribution.

3MB

Abstract

The human gut is a safe environment for several microbes that are symbiotic and important for the wellbeing of human health. However, studies on gut microbiota in different animals have suggested that changes in the composition and structure of these microbes may promote gut inflammation by releasing inflammatory cytokines and lipopolysaccharides, gut-wall leakage, and may affect systemic inflammatory and immune mechanisms that are important for the normal functioning of the body. There are many factors that aid in the gut’s dysbiosis and neuroinflammation, including high stress levels, lack of sleep, fatty and processed foods, and the prolonged use of antibiotics. These neurotoxic mechanisms of dysbiosis may increase susceptibility to Alzheimer’s disease (AD) and other neurodegenerative conditions. Therefore, studies have recently been conducted to tackle AD-like conditions by specifically targeting gut microbes that need further elucidation. It was suggested that gut dyshomeostasis may be regulated by using available options, including the use of flavonoids such as anthocyanins, and restriction of the use of high-fatty-acid-containing food. In this review, we summarize the gut microbiota, factors promoting it, and possible therapeutic interventions especially focused on the therapeutic potential of natural dietary polyflavonoid anthocyanins. Our study strongly suggests that gut dysbiosis and systemic inflammation are critically involved in the development of neurodegenerative disorders, and the natural intake of these flavonoids may provide new therapeutic opportunities for preclinical or clinical studies.

Item Type:Articles
Keywords:natural polyflavonoids, gut dysbiosis, systemic inflammation, neuroinflammation, memory impairment, Alzheimer’s disease.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Park, Tae Ju
Creator Roles:
Park, T. J.Writing – review and editing
Authors: Khan, M. S., Ikram, M., Park, J. S., Park, T. J., and Kim, M. O.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Cells
Publisher:MDPI
ISSN:2073-4409
ISSN (Online):2073-4409
Copyright Holders:Copyright © 2020 The Authors
First Published:First published in Cells 9(4):e853
Publisher Policy:Reproduced under a Creative Commons Licence

University Staff: Request a correction | Enlighten Editors: Update this record